- APIs for research and impurities
- Natural and semi-synthetic antibiotics
- Salts and Derivatives of Active Pharmaceutical Ingredients (API)
Informação sobre produto
Nome:Ivermectin EP impurity E
Sinónimos:
- (5-O,12-didemethyl-12-ethyl-22,23-dihydroavermectin A1a (12-demethyl-12-ethyl-H2B1a)
Marca:Biosynth
Descrição:Ivermectin EP impurity E is an impurity of Ivermectin. It is a natural metabolite of Ivermectin that was first identified in 1979. It is not currently used as a drug, but it has been studied for its potential to treat Parkinson's disease and other neurological disorders. Ivermectin EP impurity E has also been shown to have anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis.
Ivermectin EP impurity E is a natural metabolite of Ivermectin which was first identified in 1979. It is not currently used as a drug, but it has been studied for its potential to treat Parkinson's disease and other neurological disorders. Ivermectin EP impurity E has also been shown to have anti-inflammatory properties, which may be due to its inhibition of prostaglandins synthesis.
Aviso:Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Propriedades químicas
Peso molecular:889.12 g/mol
Fórmula:C49H76O14
Pureza:Min. 95%